Has Steven Ozeran, MD received payments from drug or device companies?

Yes. Drug and device makers reported $9,306 in general payments to Steven Ozeran, MD across 47 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Ozeran, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Ozeran, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Ozeran, MD

Plastic Surgery · Lewiston, IDNPI 1316911571

Payments from drug & device makers

What this record shows

The money is spread across several categories — gifts (50.5%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. AbbVie accounts for 94.1% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $6,436 and has fallen 96.1% since, to $252 in 2025.

$9,306in general payments, 2019–2025

Across 47 payments — averaging $197.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$9K
Kerecis Limited$296
Organogenesis Inc.$191
Polynovo North America LLC$28
Pacira Pharmaceuticals Incorporated$16
Mentor Worldwide LLC$15

What the payments were for

Speaking & faculty fees$1,94921%
Travel & lodging$1,23713%
Food & beverage$1,42015%
Gifts$4,70051%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	40	$8,760
Kerecis Limited	2	$296
Organogenesis Inc.	2	$191
Polynovo North America LLC	1	$28
Pacira Pharmaceuticals Incorporated	1	$16
Mentor Worldwide LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few plastic surgery providers in Idahoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$5,320

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic surgery in Lewiston

Louis PopplerMeridian$10K
Tyler WaymentTwin Falls$8K
Dell SmithTwin Falls$7K
Mark LeyngoldMeridian$7K
Jonathan KramerBoise$4K
Jhade WoodallIdaho Falls$4K
Jason NealyBoise$2K
Thomas McKimBoise$2K
Nicholas JohnsonIdaho Falls$1K
Dinu Mistry WolfBoise$1K

See the full list for Idaho →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →